±³¼öÁø ¼Ò°³

STSTUS ¸í¿¹±³¼ö
¼º¸í ¹ÚÀç°©
Àü¹®ºÐ¾ß ´ëÀåÇ×¹®¿Ü°ú

±¸ºÐ

Çб³ Àü°ø Á¹¾÷³âµµ

·

¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ (Çлç) · 1973

·

¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ´ëÇпø (¼®»ç, ¹Ú»ç) · 1979

±â°£

¼¼ºÎ»çÇ×

1973 - 1978

¼­¿ï´ëÇб³º´¿ø, ÀÎÅÏ ¹× ·¹Áö´øÆ®

1985 - 1987

¹Ì±¹±¹¸³¾Ï¿¬±¸¼Ò ¿¬±¸¿ø

1981 - 1994

¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ÀüÀÓ°­»ç, Á¶±³¼ö, ºÎ±³¼ö

1991 - ÇöÀç

Çѱ¹¼¼Æ÷ÁÖ¿¬±¸Àç´Ü ÀÌ»çÀå

1994 - ÇöÀç

¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ±³¼ö

1995 - 2000

¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¾Ï¿¬±¸¼Ò ¹× ¼­¿ï´ëÇб³ ¾Ï¿¬±¸¼¾ÅÍ ¼ÒÀå

1997 - 2000

¼­¿ï´ëÇб³ ´ëÇпø Á¾¾ç»ý¹°ÇÐ Çùµ¿°úÁ¤ ÁÖÀÓ±³¼ö

2000 - 2006.03

±¹¸³¾Ï¼¾ÅÍ ¿øÀå

1983 - 1985

´ëÇѸ鿪ÇÐȸ Ãѹ«1983

1993. 11. 19

´ëÇѼÒÈ­±âÇÐȸ Çмú»ó : À¯Àü¼º ºñ¿ëÁ¾Áõ ´ëÀå¾ÏÀÇ Ä¡·á

1997. 6. 26

¹Ì±¹´ëÀå¿Ü°úÇÐȸ Çмú»ó : ¡ºGermline mutations of hMLH1 and hMSH2 genes in suspected hereditary nonpolyposis colorectal cancer(HNPCC) and sporadic early- onset colorectal cancer patients¡»

2001. 4.

Çѱ¹°úÇÐÀç´ÜÁö¿ø ¿ì¼ö¿¬±¸¼º°ú 30¼± : ü³»¿Í ü¿Ü¿¡¼­ÀÇ ÀÎüÁ¾¾ç¼¼Æ÷ : ÀڱðæºÎ¾Ï ¼¼Æ÷ÁÖ 12Á¾ÀÇ ¼ö¸³

2001. 6. 20

´ëÇѹα¹ ȲÁ¶±ÙÁ¤ÈÆÀå

2002. 5. 4

´ëÇÑÀÇ»çÇùȸ ¿ì¼öÇѱ¹ÀÎ ÀÇ°úÇÐÀÚ 20ÀÎ : À¯Àü¼º¾Ï

2002. 11. 26

Çѱ¹´ã¹è¼ÒºñÀÚº¸È£Çùȸ Á¦4ȸ ´ã¹è¼ÒºñÀÚº¸È£´ë»ó ¼ÒºñÀÚº¸È£ºÎ¹®

2002. 11. 30

´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ±¹Á¦ÇÐȸÁöÇмú»ó :¡ºMutational analysis of promoters of mismatch repair genes hMSH2 and hMLH1 in hereditary nonpolyposis colorectal cancer and early onset colorectal cancer patients: identification of three novel germ-line mutations in promoter of the hMSH2 gene¡»

2003. 3. 11

Á¦2ȸ º¸·É¾ÏÇмú»ó

2003. 6. 26

Àü±¹ ÀÇ»ç ±Ý¿¬ ¼±Æ÷½Ä: ´ëÇÑÀÇ»çÇùȸ °ø·ÎÆÐ

2003. 7. 14

¼º°îÇмú¹®È­Àç´Ü Á¦18ȸ ¼º°îÇмú¹®È­»ó ÀÚ¿¬°úÇкι®

2004. 1. 28

Á¦3ȸ ¼­¿ï´ëÇб³ AMP(Advancecd Management Program) ´ë»ó

2004. 4. 21

¼­¿ï´ëÇб³º´¿ø 2003³âµµ SCI I.F ÃÖ¿ì¼ö»ó

2004. 4. 21

¼­¿ï´ëÇб³º´¿ø 2003³âµµ SCI ÀúÀÛ¿ì¼ö»ó

2004. 12. 1

Á¦4ȸ ÀÚ¶û½º·± Çѱ¹ÀÎ ´ë»ó (Çѱ¹ ¾ð·ÐÀÎ ¿¬ÇÕȸ)

2005. 5. 18

¼­¿ï´ëÇб³º´¿ø 2004³âµµ SCI I.F ¿ì¼ö»ó

2005. 5. 18

¼­¿ï´ëÇб³º´¿ø 2004³âµµ SCI ÀúÀÛ¿ì¼ö»ó

2005. 5. 31

2005 ¼¼°è±Ý¿¬Àdz¯ WHO ±Ý¿¬°ø·Î»ó

1987

Characteristics of cell lines established from human colorectal carcinoma.

1988

Enhancement of fluorinated pyrimidine-induced cytotoxicity by leucovorin in human colorectal carcinoma cell lines.

1990

Characteristics of cell lines established from human gastric carcinoma.

1993

Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer.

1995

Characterization of cell lines established from human hepatocellular carcinoma.

1996

Germline mutations of hMLH1 and hMSH2 genes in Korean hereditary nonpolyposis colorectal cancer.

1997

Establishment and characterization of human gastric carcinoma cell lines.

1997

Establishment and characterization of 12 uterine cervical-carcinoma cell lines : Common sequence variation in the E7 gene of HPV-16-positive cell lines.

1997

Establishment and characterization of human ovarian carcinoma cell lines.

1999

Establishment and characterization of human laryngeal carcinoma cell lines.

2000

E-cadherin gene promoter methylation as the second genetic hit in hereditary gastric cancer.

2000

Report on the first meeting of the International Collaborative Group on Herediatry Gastric Cancer.

2002

RET oligonucleotide microarray for the detection of RET mutations in multiple endocrine neoplasia type 2 syndromes.

2002

Mutational analysis of promoters of mismatch repair genes hMSH2 and hMLH1 in hereditary nonpolyposis colorectal cancer and early onset colorectal cancer patients: identification of three novel germ-line mutations in promoter of the hMSH2 gene.

2003

A novel germline mutation in the MET extracellular domain in a Korean patient with the diffuse type of familial gastric cancer.

2004

Germline mutations in MLH1, MSH2 and MSH6 in Korean hereditary non-polyposis colorectal cancer families.

2004

Identification of genes with differential expression in acquired drug-resistant gastric cancer cells using high-density oligonucleotide microarrays.

2005

Down-regulation of Mitochondria F1F0-ATP Synthase in Human Colon Cancer Cells with Induced 5-Fluorouracil Resistance.